LINCOLN PHARMACEUTICALS LTD.

Scale -

Revenue is 671 Rs Cr; Continuous Growth over 3 years
Quarterly Ebitda is 27.43 Rs Cr; Continuous Growth over 3 Quarters
PBT is 47.55 Rs Cr; in Top Quartile
Quarterly Profit is 36.23 Rs Cr; in Top Quartile

Profitability -

Quarterly Profit margin is 20 %; in Top Quartile

PBDIT Margin is 19.54 %; Continuous Decline over 3 years
PAT Margin is 13.09 %; Continuous Decline over 3 years

Return -

ROCE is 14.96 %; Continuous Decline over 3 years
ROA is 9.87 %; Continuous Decline over 3 years
ROE is 11.6 %; Continuous Decline over 3 years
Asset Turnover is 80 %; Continuous Decline over 3 years

Efficiency -

Inventory Turnover Ratio is 8.45; Continuous Growth over 3 years; 5 Year CAGR is 34 %
Operating cash flow is 106 Rs Cr; Continuous Growth over 3 years; in Top Quartile
Current Ratio is 5.25; in Top Quartile
Quick Ratio is 4.53; in Top Quartile

Solvancy -

Contingent Liabilities is 0 Rs Cr; Annual Decline is -100 %

Total Debt is 4.42 Rs Cr; 5 Year CAGR is 21 %

Quality -

Change in Inventories/Total Expenses is -1 %; Annual Decline is -177 %
Operating cashflow/ebitda is 81 %; Continuous Growth over 3 years
Operating cashflow/PAT is 121 %; Continuous Growth over 3 years; in Top Quartile

Current Tax/PAT is 32 %; Continuous Growth over 3 years
Other Expenses/Total Expenses is 23 %; Continuous Growth over 3 years
Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: